Volume 27, Number 1—January 2021
Dispatch
Prevalence of SARS-CoV-2, Verona, Italy, April–May 2020
Massimo Guerriero1, Zeno Bisoffi1
, Albino Poli, Claudio Micheletto, Antonio Conti, and Carlo Pomari
, Albino Poli, Claudio Micheletto, Antonio Conti, and Carlo Pomari
Table 1
Demographic and clinical characteristics of participants tested for SARS-CoV-2, Verona, Italy, 2020*
| Characteristic | Total | RNA-positive | RNA-negative/IgG-positive | RNA-negative/IgG-negative | p value† | Missing values |
|---|---|---|---|---|---|---|
| Total, no. (%) |
1,515 (100.0) |
10 (0.7) |
40 (2.6) |
1465 (96.7) |
NA |
0 |
| Mean age, y (SD) |
52.1 (20.0) |
53.4 (15.5) |
47.3 (17.6) |
52.2 (20.1) |
0.31 |
0 |
| Sex, no. | ||||||
| M | 699 | 3 | 17 | 679 | 0.57 | 0 |
| F |
816 |
7 |
23 |
786 |
0 |
|
| SARS-CoV-2 symptoms, % | ||||||
| Anosmia | 2.4 | 10.0 | 39.5 | 1.4 | <0.01 | 3.9 |
| Conjunctivitis | 8.0 | 0 | 12.8 | 7.9 | 0.38 | 3.1 |
| Temperature >37.5°C | 2.7 | 10.0 | 30.8 | 1.8 | <0.01 | 3.1 |
| Dry cough or phlegm | 9.3 | 0 | 28.2 | 8.9 | <0.01 | 3.0 |
| General muscle pain | 5.4 | 10.0 | 23.1 | 4.9 | <0.01 | 3.2 |
| Fatigue | 8.3 | 10.0 | 35.9 | 7.5 | <0.01 | 3.1 |
| Headache | 10.4 | 10.0 | 15.4 | 10.2 | 0.48 | 3.0 |
| Sore throat | 7.6 | 0 | 7.7 | 7.6 | 1.00 | 3.2 |
| Chills | 4.4 | 10.0 | 10.5 | 3.9 | <0.01 | 3.0 |
| Diarrhea | 7.9 | 20.0 | 13.2 | 7.7 | 0.09 | 3.2 |
| Dyspnea | 3.5 | 10.0 | 18.0 | 3.0 | <0.01 | 3.2 |
| Nausea/vomiting | 2.6 | 10.0 | 10.5 | 2.3 | <0.01 | 3.1 |
*Values are no. (%) except as indicated. NA, not applicable; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. †Mean difference in age tested with analysis of variance. All other p values calculated by Fisher’s exact test.
1These authors contributed equally to this article.
Page created: October 05, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.